Get the Stockscreener App
37.60
0.91%
0.34
After Hours:
37.92
0.32
+0.85%
Centene Corp stock is traded at $37.60, with a volume of 4.05M.
It is up +0.91% in the last 24 hours and up +9.14% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$37.26
Open:
$37.375
24h Volume:
4.05M
Relative Volume:
0.64
Market Cap:
$18.49B
Revenue:
$194.78B
Net Income/Loss:
$-6.68B
P/E Ratio:
-2.7602
EPS:
-13.6221
Net Cash Flow:
$4.32B
1W Performance:
+0.86%
1M Performance:
+9.14%
6M Performance:
+5.06%
1Y Performance:
-39.63%
1-Day Range:
$36.66
$37.75
1-Week Range:
$36.42
$38.21
52-Week Range:
$25.07
$64.15
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
37.60 | 18.32B | 194.78B | -6.68B | 4.32B | -13.62 |
UNH
Unitedhealth Group Inc
|
314.05 | 285.18B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
74.99 | 99.48B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
268.63 | 71.87B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
311.18 | 68.83B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
198.37 | 23.56B | 129.66B | 1.20B | 375.00M | 9.8083 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-14-25 | Initiated | Goldman | Sell |
| Jul-28-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-23-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-02-25 | Downgrade | UBS | Buy → Neutral |
| Jun-09-25 | Resumed | Morgan Stanley | Overweight |
| Jun-02-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
What Offers Centene Corporation (CNC) an Attractive Growth Outlook? - Yahoo! Finance Canada
Centene Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo
Centene Corp. stock (US15133V1035): Is Medicaid expansion strength enough to drive steady gains now? - AD HOC NEWS
Centene’s North Carolina Merger Tests Scale Benefits And Undervalued Thesis - Yahoo Finance
Centene Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
More than 500 apartments coming to former Centene campus in University City - MSN
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know - Barchart.com
Centene (CNC) Sees Positive Impact from Medicare Rate Announceme - GuruFocus
Sunshine Health Delivers Career Pathways for Floridians and Advances Healthcare Workforce - ChartMill
2026-04-07 | Bronstein, Gewirtz & Grossman, LLC Encourages Centene Corporation (CNC) Shareholders to Inquire about Securities Investigation | NYSE:CNC | Press Release - Stockhouse
UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments - Benzinga
Centene tumbles on ACA warnings but leads managed care with top buy quant rating - MSN
Centene Corp. stock: Why it's drawing investor attention amid healthcare shifts - AD HOC NEWS
Centene (CNC) Surges 5% Following CMS Medicare Payment Update - GuruFocus
CNC Merges Its North Carolina Divisions to Broaden Presence Across the State - Bitget
Centene names 2 executives to new leadership roles in restructuring - The Business Journals
CNC Combines Its North Carolina Units to Expand Statewide Footprint - TradingView
Centene Announces New Executive Leadership Structure - Finviz
Centene names two group presidents in leadership restructure - Investing.com
Centene Corporation (CNC) stock price, news, quote and history - Yahoo Finance UK
Bronstein, Gewirtz & Grossman, LLC Is Investigating Centene Corporation (CNC) And Encourages Shareholders to Connect - ACCESS Newswire
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Centene Corporation (CNC) And Encourages Shareholders to Connect | NYSE:CNC | Press Release - Stockhouse
Centene Corp. stock outperforms competitors on strong trading day - MSN
CNC PE Ratio & Valuation, Is CNC Overvalued - Intellectia AI
ENGLISH CAPITAL MANAGEMENT LLC's Centene Corp(CNC) Holding History - GuruFocus
St. Vincent Behavioral Health Campus Expands Housing & Health Care for LA with $6M Health Net Investment - Finviz
One North Carolina health plan for 980,000 members, no benefit changes - Stock Titan
Centene's Q1 2026 Earnings: What to Expect - Barchart
UBS Autocallable Notes Linked to Centene (AMUB) — $1,000 Notes, 17.21% Coupon - Stock Titan
Here’s Why Centene Corporation (CNC) Fell in Q4 - Yahoo Finance
JPMorgan Cuts PT on Centene Corporation (CNC) to $41 From $45 – Here’s Why - Insider Monkey
Flournoy Development buys 51 acres from Centene with plans to immediately start project - The Business Journals
Centene Confronts Medicaid Cuts With Multi State Affordable Housing Push - Yahoo Finance
Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period - Finviz
Centene Corp. stock underperforms Friday when compared to competitors - MarketWatch
Carolina Complete Health and Centene Foundation Announce Investment and Groundbreaking of Major Affordable Housing Initiative in Northeast Winston-Salem with McCormack Baron Salazar - ChartMill
Centene : 2026 Proxy Statement & 2025 Annual Report - marketscreener.com
Centene Corp stock faces Medicaid managed care pressures amid management uncertainty - AD HOC NEWS
Centene Corp. stock under pressure from soaring Medicaid costs and sicker member mix in Q1 2026 - AD HOC NEWS
Centene Corporation (CNC) Announces Key Leadership Changes - GuruFocus
Centene Corp (CNC) Shares Gap Down to $31.99 on Mar 25 - GuruFocus
Centene Corp stock faces uncertainty amid Medicaid redeterminations and regulatory shifts in 2026 - AD HOC NEWS
Centene Corp. stock faces pressure from Medicaid redeterminations and rising medical costs - AD HOC NEWS
Health Insurance Providers Stocks Q4 In Review: Centene (NYSE:CNC) Vs Peers - Yahoo Finance
Assenagon Asset Management S.A. Raises Stock Position in Centene Corporation $CNC - MarketBeat
Centene Corp. stock under pressure from Medicaid redeterminations and rising medical costs in Q1 202 - AD HOC NEWS
Centene Corporation Form 8-K Filing Summary for March 18, 2026 – Company Details, Stock Listing, and Compliance Information - Minichart
Centene appoints Theodore Pienkos as chief accounting officer and controller By Investing.com - Investing.com India
Centene appoints Theodore Pienkos as chief accounting officer and controller - Investing.com
Centene Corp stock faces Medicaid redetermination pressures amid 2026 policy shifts - AD HOC NEWS
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):